Literature DB >> 1312221

Mapping neuroinvasiveness of the herpes simplex virus type 1 encephalitis-inducing strain 2762 by the use of monoclonal antibodies.

T Bergström1, E Sjögren-Jansson, S Jeansson, E Lycke.   

Abstract

Monoclonal antibodies (MAbs) directed against herpes simplex virus (HSV)-coded glycoproteins gB, gC, gD and gE were employed in a an in vitro model of neuroinvasiveness using sensory neurons from rat dorsal root ganglion (DRG) cells. The neurons were cultured in at two-chamber system allowing infection via the neuritic extensions exclusively. The effects of 30 MAbs on viral replication of the encephalitis-derived HSV-1 strain 2762 and its less neuroinvasive variant 2762p11 were assayed in this model. One MAb reactive with gD gave a nine-fold reduction of the virus yields of both strains. One MAb directed against gB gave an enhanced virus yield of strain 2762, but not of the 2762p11 variant. Another gB-reactive MAb decreased the virus yield of strain 2762p11, but not of 2762 after neuritic infection. The findings indicate that an alteration of gB has occurred during the passage of the strain 2762. Mutants of the same strain were derived by infecting hybridomas producing MAb reactive with gB, gC, gD and gE, respectively. The gB hybridoma mutant showed a significantly lower neuroinvasiveness in the DRG model, and was non-virulent after snout infection of mice. We suggest that the structure of gB of the strain 2762 is of importance for the neuroinvasiveness of this strain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1312221      PMCID: PMC7135814          DOI: 10.1016/0890-8508(92)90070-e

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  28 in total

1.  Involvement of glycoprotein C (gC) in adsorption of herpes simplex virus type 1 (HSV-1) to the cell.

Authors:  B Svennerholm; S Jeansson; A Vahlne; E Lycke
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Spread of herpes simplex virus (HSV) strains SC16, ANG, ANGpath and its glyC minus and GlyE minus mutants in DBA-2 mice.

Authors:  J Rajcáni; U Herget; H C Kaerner
Journal:  Acta Virol       Date:  1990-08       Impact factor: 1.162

Review 3.  Viral encephalitis.

Authors:  R J Whitley
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

4.  Local control of neurite development by nerve growth factor.

Authors:  R B Campenot
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

5.  Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice.

Authors:  R D Dix; R R McKendall; J R Baringer
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

6.  Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis.

Authors:  R Whitley; A D Lakeman; A Nahmias; B Roizman
Journal:  N Engl J Med       Date:  1982-10-21       Impact factor: 91.245

7.  Genetic and biological analyses of a herpes simplex virus intertypic recombinant reduced specifically for neurovirulence.

Authors:  R T Javier; R L Thompson; J G Stevens
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

8.  Differences in neurovirulence among isolates of Herpes simplex virus types 1 and 2 in mice using four routes of infection.

Authors:  J T Richards; E R Kern; J C Overall; L A Glasgow
Journal:  J Infect Dis       Date:  1981-11       Impact factor: 5.226

9.  Evaluation of solubilized herpes simplex virus membrane antigen by enzyme-linked immunosorbent assay.

Authors:  S Jeansson; M Forsgren; B Svennerholm
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

10.  Glycoprotein C of herpes simplex virus type 1: characterization of O-linked oligosaccharides.

Authors:  S Olofsson; I Sjöblom; M Lundström; S Jeansson; E Lycke
Journal:  J Gen Virol       Date:  1983-12       Impact factor: 3.891

View more
  13 in total

1.  B-cell epitopes of varicella-zoster virus glycoprotein II.

Authors:  A Kjartansdóttir; E Lycke; S R Norrby
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

2.  Variability of the glycoprotein G gene in clinical isolates of herpes simplex virus type 1.

Authors:  E Rekabdar; P Tunbäck; J A Liljeqvist; T Bergström
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

3.  Herpes simplex virus type 2 glycoprotein G-negative clinical isolates are generated by single frameshift mutations.

Authors:  J A Liljeqvist; B Svennerholm; T Bergström
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease.

Authors:  Staffan Görander; Ali M Harandi; Madelene Lindqvist; Tomas Bergström; Jan-Åke Liljeqvist
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

5.  Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate.

Authors:  E Trybala; J A Liljeqvist; B Svennerholm; T Bergström
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Typing of clinical herpes simplex virus type 1 and type 2 isolates with monoclonal antibodies.

Authors:  J A Liljeqvist; B Svennerholm; T Bergström
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

7.  Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolates.

Authors:  Elham Rekabdar; Petra Tunbäck; Jan-Ake Liljeqvist; Magnus Lindh; Tomas Bergström
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  HSV-1 strain McKrae is more neuroinvasive than HSV-1 KOS after corneal or vaginal inoculation in mice.

Authors:  Hong Wang; David J Davido; Lynda A Morrison
Journal:  Virus Res       Date:  2013-01-20       Impact factor: 3.303

9.  Herpes simplex virus type 1-induced hemagglutination: glycoprotein C mediates virus binding to erythrocyte surface heparan sulfate.

Authors:  E Trybala; B Svennerholm; T Bergström; S Olofsson; S Jeansson; J L Goodman
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

10.  The Cholestanol-Conjugated Sulfated Oligosaccharide PG545 Disrupts the Lipid Envelope of Herpes Simplex Virus Particles.

Authors:  Joanna S Said; Edward Trybala; Staffan Görander; Maria Ekblad; Jan-Åke Liljeqvist; Eva Jennische; Stefan Lange; Tomas Bergström
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.